Stochastic analysis of heart rate variability and its relation to echocardiography parameters in hypertrophic

M Petelczyc1, J J Zebrowski, R Baranowski

  • 1Faculty of Physics, Warsaw University of Technology, Koszykowa 75, Warsaw, Poland. petelczyc_m@if.pw.edu.pl

Physiological Measurement
|November 13, 2010
PubMed

Insights

Heart rate variability analysis using Kramers-Moyal expansion reveals new parameters for hypertrophic cardiomyopathy (HCM). The LCF-RCF parameter may diagnose HCM by measuring its effect on heart rate variability.

Area of Science:

  • Cardiology
  • Biophysics
  • Nonlinear Dynamics

Background:

  • Heart rate variability (HRV) is a crucial indicator of cardiac autonomic function.
  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac disease affecting heart rate regulation.
  • Traditional HRV analysis may not fully capture the intricate dynamics in HCM.

Purpose of the Study:

  • To investigate HRV in healthy individuals and HCM patients using advanced dynamical analysis.
  • To introduce novel parameters derived from the Langevin equation to characterize HRV.
  • To explore the diagnostic potential of these new parameters in HCM.

Main Methods:

  • Analysis of RR interval time series from 10 healthy males and 49 HCM patients.
  • Application of Kramers-Moyal expansion to extract drift and diffusion terms of the Langevin equation.
  • Introduction and calculation of new diffusion term parameters: Left (LCF) and Right (RCF) Branch Coefficients.
  • Correlation of LCF-RCF with echocardiographic parameters, specifically left ventricular systolic diameter.

Main Results:

  • The LCF-RCF parameter was calculated for all participants.
  • HCM patients were categorized into three groups based on the LCF-RCF difference and left ventricular systolic diameter.
  • Significant differences in HRV properties were observed between HCM patients and healthy controls.
  • The LCF-RCF parameter demonstrated a strong association with the impact of HCM on HRV.

Conclusions:

  • The LCF-RCF parameter, derived from Kramers-Moyal expansion, shows potential as a novel biomarker for HCM.
  • This parameter may offer valuable diagnostic insights into the effects of HCM on heart rate variability.
  • Further research can validate LCF-RCF for clinical application in HCM diagnosis and management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Correlation between ECG and Cardiac Cycle01:25

Correlation between ECG and Cardiac Cycle

The electrical signals recorded on an electrocardiogram (ECG) occur before the mechanical processes of contraction and relaxation during the cardiac cycle.
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...